JAZZ vs PBHC · P/E 1988, rev $2.28B vs P/E 25, rev $35.6M
Jazz Pharmaceuticals PLC (JAZZ) versus Pathfinder Bancorp Inc (PBHC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Pathfinder Bancorp Inc (PBHC) is a banks - regional company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PBHC revenue for 2026-06-30 was $35.6M. Net income was $5.1M. PBHC currently screens at market cap $91.9M and trailing P/E 24.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PBHC currently screens at market cap $91.9M and trailing P/E 24.5.
Not investment advice. Open the JAZZ and PBHC stock pages for the full models.
Not investment advice.